Ticker Scorecard - VRTX Basics Company: Vertex Pharmaceuticals Incorporated IPO Date: July 24, 1991 Sector: Healthcare Industry: Biotech Market Cap: $124.35B Activated in VL: True Average Daily Range Avg Daily Range: $1.71 | 1.69% Avg Daily Range (30 D): $5.18 | 1.15% Avg Daily Range (90 D): $5.70 | 1.24% Institutional Daily Volume Avg Daily Volume: 1.6M Avg Daily Volume (30 D): 1.23M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 34 Avg Trade Size (Sh.) (90 D): 35 Institutional Trades Total Inst.Trades: 29,313 Avg Inst. Trade: $7.72M Avg Inst. Trade (30 D): $28.51M Avg Inst. Trade (90 D): $30.82M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $28.03M Avg Closing Trade (30 D): $99.68M Avg Closing Trade (90 D): $108.33M Avg Closing Volume: 140.47K     News Feb 22, 2025 @ 10:47 AM 3 Magnificent Growth Stocks to Buy Right Now Source: The Motley Fool Feb 21, 2025 @ 10:50 AM 2 No-Brainer Healthcare Stocks to Buy With $500 Ri... Source: Keith Speights Feb 16, 2025 @ 12:06 PM Bahrain Makes History with First Successful CRISPR... Source: N/A Feb 15, 2025 @ 1:45 PM 2 Healthcare Stocks That Tumbled in 2024...but Cou... Source: The Motley Fool Feb 14, 2025 @ 10:47 AM The Ultimate Healthcare Stock to Buy With $500 Rig... Source: Keith Speights Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.08 $3.53 $-2.08 Diluted EPS $-2.08 $3.53 $-2.08 Revenue $ 11.02B $ 2.91B $ 11.02B Gross Profit $ 9.49B $ 2.49B $ 9.49B Net Income / Loss $ -535.6M $ 913M $ -535.6M Operating Income / Loss $ -232.9M $ 1.03B $ -232.9M Cost of Revenue $ 1.53B $ 423.4M $ 1.53B Net Cash Flow $ -5800.1M $ -675.9M $ -5800.1M PE Ratio     Splits Aug 24, 2000:   1:2